Selective serotonin reuptake inhibitors to improve outcome in acute ischemic stroke: Possible mechanisms and clinical evidence

Brain and Behavior

Volumn 5, Issue 10, 2015, Pages

  Siepmann, Timo ^a   Penzlin, Ana Isabel ^a   Kepplinger, Jessica ^a   Illigens, Ben Min Woo ^b   Weidner, Kerstin ^a   Reichmann, Heinz ^a   Barlinn, Kristian ^a  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Acute ischemic stroke; Fluoxetine; SSRI

Indexed keywords

FLUOXETINE; SEROTONIN UPTAKE INHIBITOR;

AUTONOMIC NERVOUS SYSTEM FUNCTION; BEHAVIOR; BIBLIOGRAPHIC DATABASE; BRAIN BLOOD FLOW; BRAIN ISCHEMIA; CLINICAL EVALUATION; EVIDENCE BASED PRACTICE; EVOKED BRAIN STEM AUDITORY RESPONSE; HUMAN; INFORMATION PROCESSING; META ANALYSIS (TOPIC); NERVE CELL EXCITABILITY; NERVE CELL PLASTICITY; NEUROPROTECTION; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW (TOPIC); ANIMAL; CONVALESCENCE; META ANALYSIS; STROKE;

ANIMALS; FLUOXETINE; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECOVERY OF FUNCTION; SEROTONIN UPTAKE INHIBITORS; STROKE;

EID: 84945209058     PISSN: None     EISSN: 21623279     Source Type: Journal    
DOI: 10.1002/brb3.373     Document Type: Review

References (43)

1. Acler, M., E. Robol, A. Fiaschi, and P. Manganotti . 2009. A double blind placebo RCT to investigate the effects of serotonergic modulation on brain excitability and motor recovery in stroke patients. J. Neurol. 256:1152-1158.
2. Barlinn, K., J. Kepplinger, V. Puetz, B. M. Illigens, U. Bodechtel, and T. Siepmann . 2014. Exploring the risk-factor association between depression and incident stroke: a systematic review and meta-analysis. Neuropsychiatr. Dis. Treat. 11:1-14.
3. Berkhemer, O. A., P. S. Fransen, D. Beumer, van den Berg L. A., H. F. Lingsma, A. J. Yoo, et al. 2015. A randomized trial of intraarterial treatment for acute ischemic stroke. N. Eng. J. Med. 372:11-20.
4. Budhdeo, S., and G. Deluca . 2012. BDNF: a possible explanation of findings from the FLAME trial. Int. J. Stroke 7:E2.
5. Chollet, F., V. DiPiero, R. J. S. Wise, D. J. Brooks, R. J. Dolan, and R. S. J. Frackowiak . 1991. The functional anatomy of motor recovery after stroke in humans: a study with positron emission tomography. Ann. Neurol. 26:63-71.
6. Chollet, F., J. Tardy, J. F. Albucher, C. Thalamas, E. Berard, C. Lamy, et al. 2011. Fluoxetine for motor recovery after acute ischaemic stroke (FLAME): a randomised placebo-controlled trial. Lancet Neurol. 10:123-130.
7. Cramer, S. C. 2011. Listening to fluoxetine: a hot message from the FLAME trial of poststroke motor recovery. Int. J. Stroke 6:315-316.
8. Cramer, S. C., G. Nelles, R. R. Benson, J. D. Kaplan, R. A. Parker, K. K. Kwong, et al. 1997. A functional MRI study of subjects recovered from hemiparetic stroke. Stroke 28:2518-2527.
9. Dam, M., P. Tonin, A. De Boni, G. Pizzolato, S. Casson, M. Ermani, et al. 1996. Effects of fluoxetine and maprotiline on functional recovery inpoststroke hemiplegic patients undergoing rehabilitation therapy. Stroke 27:1211-1214.
10. Dempsey, R. J., K. A. Sailor, K. K. Bowen, K. Tureyen, and R. Vemuganti . 2003. Stroke-induced progenitor cell proliferation in adult spontaneously hypertensive rat brain: effect of exogenous IGF-1 and GDNF. J. Neurochem. 87:586-597.
11. Dirnagl, U., C. Iadecola, and M. A. Moskowitz . 1999. Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci. 22:391-397.
12. Go, A. S., D. Mozaffarian, V. L. Roger, E. J. Benjamin, J. D. Berry, M. J. Blaha, et al. 2014. Heart disease and stroke statistics-2014 update: a report from the American Heart Association. Circulation 129:e28-e292.
13. Goyal, M., A. M. Demchuk, B. K. Menon, M. Eesa, J. L. Rempel, J. Thornton, et al. Randomized assessment of rapid endovascular treatment of ischemic stroke. N. Eng. J. Med. 2015 372:1019-1030.
14. Gu, W., T. Brannstrom, and P. Wester . 2000. Cortical neurogenesis in adult rats after reversible photothrombotic stroke. J. Cereb. Blood Flow Metab. 20:1166-1173.
15. Hacke, W., M. Kaste, E. Bluhmki, M. Brozman, A. Dávalos, D. Guidetti, et al.; ECASS Investigators. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N. Eng. J. Med. 2008 359:1317-1329.
16. Jiang, W., W. Gu, T. Brannstrom, R. Rosqvist, and P. Wester . 2001. Cortical neurogenesis in adult rats after transient middle cerebral artery occlusion. Stroke 32:1201-1207.
17. Kirino, T. 2000. Delayed neuronal death. Neuropathology 20:95-97.
18. Kraglund, K. L., J. K. Mortensen, E. L. Grove, S. P. Johnsen, and G. Andersen . 2015. TALOS: a multicenter, randomized, double-blind, placebo-controlled trial to test the effects of citalopram in patients with acute stroke. Int. J. Stroke 10:985-987.
19. Lang, U. E., M. C. Jockers-Scherubl, and R. Hellweg . 2004. State of the art of the neurotrophin hypothesis in psychiatric disorders: implications and limitations. J. Neural. Transm. 111:387-411.
20. Lim, C. M., S. W. Kim, J. Y. Park, C. Kim, S. H. Yoon, and J. K. Lee . 2009. Fluoxetine affords robust neuroprotection in the postischemic brain via its anti-inflammatory effect. J. Neurosci. Res. 87:1037-1045.
21. Liu, J., K. Solway, R. O. Messing, and F. R. Sharp . 1998. Increased neurogenesis in the dentate gyrus after transient global ischemia in gerbils. J. Neurosci. 18:7768-7778.
22. Lutz, W., W. Sanderson, and S. Scherbov . 2008. The coming acceleration of global population ageing. Nature 451:716-719.
23. Majeed, F., and A. K. Kamal . 2011. Can selective serotonin reuptake inhibitors (SSRI) improve motor recovery after stroke? What is the role of neuroplasticity? J. Pakist. Med. Associat. 61:1147-1148.
24. Malberg, J. E., A. J. Eisch, E. J. Nestler, and R. S. Duman . 2000. Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J. Neurosci. 20:9104-9110.
25. McCann, S. K., C. Irvine, G. E. Mead, E. S. Sena, G. L. Currie, K. E. Egan, et al. 2014. Efficacy of antidepressants in animal models of ischemic stroke: a systematic review and meta-analysis. Stroke 45:3055-3063.
26. Mead, G. Fluoxetine or Control under Supervision (FOCUS) trial: to establish the effect(s) of routine administration of Fluoxetine in patients with a recent stroke ISRCTN registry; ISRCTN83290762. doi: 10.1186/ISRCTN83290762.
27. Mead, G. E., C. F. Hsieh, R. Lee, M. A. Kutlubaev, A. Claxton, G. J. Hankey, et al. 2012. Selective serotonin reuptake inhibitors (SSRIs) for stroke recovery. Cochrane Database Syst. Rev. 11:CD009286.
28. Mead, G. E., M. Dennis, E. Lundstrom, V. Murray, M. Hackett, and G. J. Hankey . 2013. Letter by Mead et al. regarding article, "Selective serotonin reuptake inhibitors for stroke: more trials are needed". Stroke 44:e40-e41.
29. Mikami, K., R. E. Jorge, H. P. Jr Adams, P. H. Davis, E. C. Leira, M. Jang, et al. 2011. Effect of antidepressants on the course of disability following stroke. Am. J. Geriatr. Psychiatry 19:1007-1015.
30. Mortensen, J. K., and G. Andersen . 2015. Safety of selective serotonin reuptake inhibitor treatment in recovering stroke patients. Expert Opin. Drug Saf. 6:911-919.
31. Mortensen, J. K., H. Larsson, S. P. Johnsen, and G. Andersen . 2014. Impact of prestroke selective serotonin reuptake inhibitor treatment on stroke severity and mortality. Stroke 45:2121-2123.
32. Mu, Y., and F. H. Gage . 2011. Adult hippocampal neurogenesis and its role in Alzheimer's disease. Mol. Neurodegener. 6:85.
33. Ozaki, H., A. Y. Yu, N. Della, K. Ozaki, J. D. Luna, H. Yamada, et al. 1999. Hypoxia inducible factor-1alpha is increased in ischemic retina: temporal and spatial correlation with VEGF expression. Invest. Ophthalmol. Vis. Sci. 40:182-189.
34. Palvimaki, E.-P., A. Laakso, M. Kuoppamaki, E. Syvilahti, and J. Hietala . 1994. Up-regulation of beta l-adrenergic receptors in rat brain after chronic citalopram and fluoxetine treatments. Psychopharmacology 115:543-546.
35. Pariente, J., I. Loubinoux, C. Carel, J. F. Albucher, A. Leger, C. Manelfe, et al. 2001. Fluoxetine modulates motor performance and cerebral activation of patients recovering from stroke. Ann. Neurol. 6:718-729.
36. Santarelli, L., M. Saxe, C. Gross, A. Surget, F. Battaglia, S. Dulawa, et al. 2003. Requirement of hippocampal neurogenesis antidepressant treatments and animal models of depressive-like behaviour. Behav. Pharmacol. 301:805-809.
37. Schmidt, H. D., and R. S. Duman . 2007. The role of neurotrophic factors in adult hippocampal neurogenesis, antidepressant treatments and animal models of depressive-like behaviour. Behav. Pharmacol. 18:391-418.
38. Shin, T. K., M. S. Kang, H. Y. Lee, M. S. Seo, S. G. Kim, C. D. Kim, et al. 2009. Fluoxetine and sertraline attenuate postischemic brain injury in mice. Korean J. Physiol. Pharmacol. 13:257-263.
39. Siepmann, T., J. Kepplinger, C. Zerna, U. Schatz, A. I. Penzlin, L. Pallesen, et al. 2015. The effects of pretreatment versus de novo treatment with selective serotonin reuptake inhibitors on short-term outcome after acute ischemic stroke. J. Stroke Cerebrovasc. Dis. 24:1886-1892.
40. Taupin, P. 2006. Adult neurogenesis and neuroplasticity. Restor. Neurol. Neurosci. 24:9-15.
41. Tiradentes, R. V., J. G. Pires, N. F. Silva, A. G. Ramage, C. H. Santuzzi, and H. A. Futuro Neto . 2014. Effects of acute administration of selective serotonin reuptake inhibitors on sympathetic nerve activity. Braz. J. Med. Biol. Res. 47:554-559.
42. Wiltrout, C., B. Lang, Y. Yan, R. J. Dempsey, and R. Vemuganti . 2007. Repairing brain after stroke: a review on post-ischaemic neurogenesis. Neurochem. Int. 50:1028-1041.
43. Zittel, S., C. Weiller, and J. Liepert . 2008. Citalopram improves dexterity in chronic stroke patients. Neurorehabilit. Neural Rep. 22:311-314.